{
    "2021-02-14": [
        [
            {
                "time": "",
                "original_text": "港股IPO|贝达药业拟A+H股上市，两款自研癌症靶向创新药已商业化",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "A+H股上市",
                        "癌症靶向创新药",
                        "商业化"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}